Brief: Renovaro Inc And Amsterdam Umc Cancer Center Poised To Advance Cancer Immunotherapy
24/05/2024 15:29
May 24 (Reuters) - Renovaro Inc RENB.O :
* RENOVARO INC - CO AND AMSTERDAM UMC CANCER CENTER POISED TO ADVANCE CANCER IMMUNOTHERAPY
* RENOVARO INC - SIGNED MOU TO ESTABLISH JOINT COMPANY BASED IN NETHERLANDS AIMED AT
PIONEERING
NEXT GENERATION OF PERSONALIZED CANCER IMMUNOTHERAPY
* RENOVARO INC - PROPOSED NEWCO WILL BE HEADQUARTERED IN AMSTERDAM, NETHERLANDS
Source text for Eikon: ID:n0001731122-24-000877
Further company coverage: RENB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing